Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients

BACKGROUND: About 40 % of women with breast cancer achieve a pathologic complete response in the breast after neoadjuvant systemic treatment (NST). To identify these women, vacuum-assisted biopsy (VAB) was evaluated to facilitate risk-adaptive surgery. In confirmatory trials, the rates of missed res...

Descripción completa

Detalles Bibliográficos
Autores principales: Koelbel, Vivian, Pfob, André, Schaefgen, Benedikt, Sinn, Peter, Feisst, Manuel, Golatta, Michael, Gomez, Christina, Stieber, Anne, Bach, Paul, Rauch, Geraldine, Heil, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724060/
https://www.ncbi.nlm.nih.gov/pubmed/34581923
http://dx.doi.org/10.1245/s10434-021-10847-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724060/
https://www.ncbi.nlm.nih.gov/pubmed/34581923
http://dx.doi.org/10.1245/s10434-021-10847-9

Ejemplares similares